Detalhe da pesquisa
1.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Nature
; 592(7854): 450-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762733
2.
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
Hepatology
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447034
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
4.
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Gastroenterology
; 165(4): 1041-1052, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442301
5.
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event.
Hepatology
; 78(4): 1149-1158, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190823
6.
The Hammersmith Score optimises patient selection and predicts for overall survival in early-phase cancer trial participants independent of tumour burden.
Chemotherapy
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679017
7.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788059
8.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
9.
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
J Hepatol
; 79(1): 69-78, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858157
10.
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
Clin Gastroenterol Hepatol
; 21(7): 1854-1863.e10, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244661
11.
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis.
Clin Gastroenterol Hepatol
; 21(9): 2308-2317.e7, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481475
12.
Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Clin Gastroenterol Hepatol
; 21(9): 2318-2326.e7, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842118
13.
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
Clin Gastroenterol Hepatol
; 21(4): 978-987.e2, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533994
14.
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
Hepatology
; 76(6): 1563-1575, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596929
15.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
16.
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis.
Liver Int
; 43(10): 2220-2231, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37469291
17.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
18.
Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
Eur Radiol
; 33(2): 1422-1432, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166087
19.
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.
Future Oncol
; 19(7): 499-507, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097715
20.
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
J Hepatol
; 76(5): 1090-1099, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066090